Delivery Order SPE2DB22D2206-SPE2DB24FHR66
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Rinvoq ER 45 mg tablets. The contract has a ceiling value of $11,803.72 and a completion date of July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,866.70, is for the delivery of the medication Rinvoq ER 45 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 17, 2025. The contract is not set-aside and was openly competed. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,847.40, is for the supply of the medication RINVOQ ER 15 MG TABLET. The contract is a firm fixed-price delivery order with an ultimate completion date of April 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rinvoq ER 15 mg tablets, a medication used to treat various medical conditions. The contract has a ceiling value of $10,863.82 and a performance period ending on January 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,431.02, is for the supply of Rinvoq ER 15 mg Tablets. The contract is a firm fixed-price delivery order, with a completion date of May 9, 2024. The contract was not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $115,428.50 Firm Fixed Price contract is for Rinvoq ER 15 mg Tablets, with an ultimate completion date of October 6, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a vehicle for providing a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Rinvoq ER 15 mg tablets, a specialty medication, to support federal healthcare programs. The contract has a ceiling value of $21,210.62 and runs through September 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,838.18, is a firm fixed-price contract for the procurement of the medication Rinvoq ER 45 mg tablets. The contract has a period of performance through March 3, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider. The $9,334.95 firm fixed-price contract is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a medication product. The contract has an ultimate completion date of January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $6,767.61, is for the supply of the prescription drug Rinvoq ER 15 mg tablets, which are used to treat various medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of December 19, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) held by...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FHR66Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,579.05, is for the supply of the medication Rinvoq ER 45 mg tablets. The contract has an ultimate completion date of June 11, 2024 and uses a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 6/10/24 |